SCHEMBL2860957

SCHEMBL2860957

Fc1cccc(-c2n[nH]c3ccccc23)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.66
IDO1 P14902 3/20 0.65
TTK P33981 2/20 0.65
KDM4E B2RXH2 2/20 0.65
ALDH1A1 P00352 2/20 0.65
HPGD P15428 2/20 0.65
ALPL P05186 1/20 0.65
GAA P10253 1/20 0.65
MAPK10 P53779 1/20 0.65
MAP2K4 P45985 5/20 0.63
MAPK1 P28482 1/20 0.59
MAPKAPK3 Q16644 1/20 0.59
MAPK6 Q16659 1/20 0.59
FADS1 O60427 1/20 0.55
TDO2 P48775 1/20 0.55
LRRK2 Q5S007 1/20 0.54
NPC1 O15118 1/20 0.51
TP53 P04637 1/20 0.51
RAB9A P51151 1/20 0.51
MAP2K7 O14733 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12317930 0.86 IDO1 (0.63) AURKAIDO1TTKKDM4EALDH1A1
SCHEMBL18977088 0.82 TTK (0.75) AURKAIDO1TTKKDM4EALDH1A1
SCHEMBL5767752 0.81 KDM4E (0.51) AURKAIDO1TTKKDM4EALDH1A1
SCHEMBL14516332 0.81 AURKA (0.59) AURKATTKMAP2K4TDO2ITK
SCHEMBL2860721 0.81 AXL (0.61) AURKATTKMAP2K4MAPK1MAPKAPK3
SCHEMBL4144451 0.81 MAP2K4 (0.53) IDO1MAP2K4TDO2LRRK2MAP2K7
SCHEMBL4153296 0.81 CLK2 (0.52) IDO1MAP2K4LRRK2MAP2K7
SCHEMBL19597646 0.81 TTK (0.72) AURKAIDO1TTKKDM4EALDH1A1
SCHEMBL5377572 0.80 ALDH1A1 (0.71) AURKAIDO1TTKKDM4EALDH1A1
SCHEMBL694710 0.80 MAP2K4 (0.48) AURKAIDO1TTKKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 AURKA 502/4885IDO1 784/4885TTK 1201/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 AURKA 779/4885IDO1 959/4885TTK 1066/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 AURKA 502/4885IDO1 784/4885TTK 1201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.